Dialysis study questions need for routine access checks
NCT ID NCT05906550
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looked at whether it is safe to stop regularly checking blood flow in the arm veins used for dialysis. Instead, doctors would only treat problems when they cause symptoms during dialysis. The goal was to see if this approach reduces the number of procedures and medical costs. The study involved 375 adults with kidney failure who were on dialysis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIALYSIS ACCESS MALFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bravis Ziekenhuis
Roosendaal, Netherlands
-
Deventer Ziekenhuis
Deventer, Netherlands
-
Diapriva - Dialyse Centrum Amsterdam
Amsterdam, Netherlands
-
Franciscus Gasthuis & Vlietland
Rotterdam, Netherlands
-
Isala Klinieken
Zwolle, Netherlands
-
Leids Universitair Medisch Centrum
Leiden, Netherlands
-
Maastricht UMC+
Maastricht, Netherlands
-
Maxima Medisch Centrum
Veldhoven, Netherlands
-
Medisch Spectrum Twente
Enschede, Netherlands
-
OLVG
Amsterdam, Netherlands
-
Spaarne Gasthuis
Haarlem, Netherlands
-
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
-
Zuyderland Medisch Centrum
Heerlen, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug work safely in patients with kidney failure?
- What does life feel like for children with a rare birth defect? a new study asks
- AI therapy coach aims to ease distress in seriously ill seniors
- A simple stretch during dialysis might soothe restless legs
- A regenerative graft could rethink dialysis access
- Pumpkin seed oil may fight inflammation in kidney patients โ a trial puts it to the test